DataElement

publicId 15157297 version 2 longName Tumor Residual Disease Status shortName 15157296v2.00:15181851v1.00 definition The persistence of tumor cells in the body at a particular time following cancer treatment. context CRDC origin CRDC:Cancer Research Data Commons workflowStatus RELEASED registrationStatus Standard latestVersionIndicator Yes beginDate 2024-09-26 endDate changeDescription administrativeNotes 9/8/25 Versioned to update OC to reflect the current PV list and to restore “tumor” to LN and definition that was removed as part of the CRDC RFC66 finalization last summer. mr; 10/16/24 Upd def to remove 'tumor' since not in the semantics. mr; 10/10/24 Released per RFC66. mr; 10/7/24 Added CRDC std CSI, alt name, alt def. mr; 9/26/24 created for CRDC RFC66. jk unresolvedIssues deletedIndicator No createdBy COLBERTM dateCreated 2025-09-08 modifiedBy COLBERTM dateModified 2025-09-08 DataElementConcept publicId 15157296 version 2 longName Tumor Residual Disease shortName 2404687v1.00:7063039v1.00 definition A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:The persistence of tumor cells in the body following cancer treatment. context CRDC origin CRDC:Cancer Research Data Commons workflowStatus RELEASED registrationStatus Qualified latestVersionIndicator Yes beginDate 2024-09-26 endDate changeDescription administrativeNotes 9/8/25 Versioned to update OC to reflect the current PV list and to reinstate “tumor” that was removed as part of the CRDC RFC66 finalization last summer. mr; 10/16/24 Upd to remove 'Tumor' from LN. mr; 10/10/24 Released per RFC 66 with CDE 15157297 Disease Residual Tumor Status. mr; 9/26/24 created for CRDC RFC66; use syn for property. jk unresolvedIssues deletedIndicator No createdBy COLBERTM dateCreated 2025-09-08 modifiedBy COLBERTM dateModified 2025-09-08 ObjectClass publicId 2404687 version 1 longName Neoplasm shortName C3262 definition (NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth. context NCIP origin NCI Thesaurus workflowStatus RELEASED registrationStatus Application latestVersionIndicator Yes beginDate 2005-09-12 endDate changeDescription administrativeNotes unresolvedIssues deletedIndicator No createdBy CAMPBELB dateCreated 2005-09-12 modifiedBy ONEDATA dateModified 2005-09-12 Concepts longName Neoplasm conceptCode C3262 definition A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias. evsSource NCI_CONCEPT_CODE primaryIndicator Yes displayOrder 0 Property publicId 7063039 version 1 longName Residual Disease shortName C4809 definition Cancer cells that remain after attempts to remove the cancer have been made. context NCIP origin NCI Thesaurus workflowStatus RELEASED registrationStatus Application latestVersionIndicator Yes beginDate 2019-11-20 endDate changeDescription administrativeNotes unresolvedIssues deletedIndicator No createdBy KNABLEJ dateCreated 2019-11-20 modifiedBy ONEDATA dateModified 2019-11-20 Concepts longName Residual Disease conceptCode C4809 definition The persistence of tumor cells in the body following cancer treatment. evsSource NCI_CONCEPT_CODE primaryIndicator Yes displayOrder 0 ConceptualDomain publicId 2435018 version 1 longName Clinical or Research Activity shortName C16203 definition Any specific activity undertaken during the course of a clinical study or research protocol. context NCIP origin NCI Thesaurus workflowStatus RELEASED registrationStatus Application latestVersionIndicator Yes beginDate 2005-12-06 endDate changeDescription administrativeNotes unresolvedIssues deletedIndicator No createdBy CURTIST dateCreated 2005-12-06 modifiedBy SBR dateModified 2006-12-20 ValueDomain publicId 15181851 version 1 longName Residual Disease Status shortName 15181851v1.00 definition The persistence of tumor cells in the body following cancer treatment._A condition or state at a particular time. context CRDC type Enumerated dataType CHARACTER minLength maxLength 25 minValue maxValue decimalPlace origin CRDC:Cancer Research Data Commons workflowStatus RELEASED registrationStatus Qualified latestVersionIndicator Yes beginDate 2024-10-16 endDate changeDescription administrativeNotes 9/8/25 Released per RFC66. mr; 10/16/24 Created per RFC 66. mr unresolvedIssues deletedIndicator No createdBy COLBERTM dateCreated 2024-10-16 modifiedBy COLBERTM dateModified 2025-09-08 PermissibleValues publicId 9175044 value R0 valueDescription origin beginDate 2024-10-16 endDate deletedIndicator No createdBy COLBERTM dateCreated 2024-10-16 modifiedBy COLBERTM dateModified 2024-10-16 ValueMeaning publicId 15181854 version 1 longName R0 shortName 15181854v1.00 definition No detectable presence of residual tumor after treatment context NCIP origin workflowStatus RELEASED registrationStatus Application latestVersionIndicator Yes beginDate 2024-10-16 endDate changeDescription administrativeNotes unresolvedIssues deletedIndicator No createdBy COLBERTM dateCreated 2024-10-16 modifiedBy COLBERTM dateModified 2024-10-16 Concepts longName R0 conceptCode C139578 definition No detectable presence of residual tumor after treatment evsSource NCI_CONCEPT_CODE primaryIndicator Yes displayOrder 0 publicId 9175045 value RX valueDescription origin beginDate 2024-10-16 endDate deletedIndicator No createdBy COLBERTM dateCreated 2024-10-16 modifiedBy COLBERTM dateModified 2024-10-16 ValueMeaning publicId 15181857 version 1 longName RX shortName 15181857v1.00 definition Presence of residual tumor after treatment cannot be assessed. context NCIP origin workflowStatus RELEASED registrationStatus Application latestVersionIndicator Yes beginDate 2024-10-16 endDate changeDescription administrativeNotes unresolvedIssues deletedIndicator No createdBy COLBERTM dateCreated 2024-10-16 modifiedBy COLBERTM dateModified 2024-10-16 Concepts longName RX conceptCode C139581 definition Presence of residual tumor after treatment cannot be assessed. evsSource NCI_CONCEPT_CODE primaryIndicator Yes displayOrder 0 publicId 9175046 value R2 valueDescription origin beginDate 2024-10-16 endDate deletedIndicator No createdBy COLBERTM dateCreated 2024-10-16 modifiedBy COLBERTM dateModified 2024-10-16 ValueMeaning publicId 15181856 version 1 longName R2 shortName 15181856v1.00 definition Presence of macroscopic residual tumor after treatment. context NCIP origin workflowStatus RELEASED registrationStatus Application latestVersionIndicator Yes beginDate 2024-10-16 endDate changeDescription administrativeNotes unresolvedIssues deletedIndicator No createdBy COLBERTM dateCreated 2024-10-16 modifiedBy COLBERTM dateModified 2024-10-16 Concepts longName R2 conceptCode C139580 definition Presence of macroscopic residual tumor after treatment. evsSource NCI_CONCEPT_CODE primaryIndicator Yes displayOrder 0 publicId 9175047 value R1 valueDescription origin beginDate 2024-10-16 endDate deletedIndicator No createdBy COLBERTM dateCreated 2024-10-16 modifiedBy COLBERTM dateModified 2024-10-16 ValueMeaning publicId 15181855 version 1 longName R1 shortName 15181855v1.00 definition Presence of microscopic residual tumor after treatment. context NCIP origin workflowStatus RELEASED registrationStatus Application latestVersionIndicator Yes beginDate 2024-10-16 endDate changeDescription administrativeNotes unresolvedIssues deletedIndicator No createdBy COLBERTM dateCreated 2024-10-16 modifiedBy COLBERTM dateModified 2024-10-16 Concepts longName R1 conceptCode C139579 definition Presence of microscopic residual tumor after treatment. evsSource NCI_CONCEPT_CODE primaryIndicator Yes displayOrder 0 publicId 9175048 value Not Reported valueDescription origin beginDate 2024-10-16 endDate deletedIndicator No createdBy COLBERTM dateCreated 2024-10-16 modifiedBy COLBERTM dateModified 2024-10-16 ValueMeaning publicId 5612322 version 1 longName Not Reported shortName 5612322v1.00 definition Not provided or available. context NCIP origin workflowStatus RELEASED registrationStatus Application latestVersionIndicator Yes beginDate 2017-01-03 endDate changeDescription administrativeNotes 3/4/25 Added alt VM names per RFC 26 CR 1. sl; 10/10/23 changed Long Name from "Not Stated" to match NCIt Preferred name and current caDSR concept Long Name of "Not Reported" per Brenda.Janice . LS unresolvedIssues deletedIndicator No createdBy ALEYR dateCreated 2017-01-03 modifiedBy SLAUER dateModified 2025-03-04 Concepts longName Not Reported conceptCode C43234 definition Not provided or available. evsSource NCI_CONCEPT_CODE primaryIndicator Yes displayOrder 0 Designations languageName ENGLISH name Not reported type VM Alt Name context COG id EDAF8130-FB17-4970-E053-731AD00A3E2F createdBy Angela Kummerow dateCreated 2022-11-17 modifiedBy KUMMEROA dateModified 2022-11-17 languageName ENGLISH name Not reported type PCDC Alt Name context Pediatric Cancer id F70C841B-1BAB-3136-E053-731AD00AEC0A createdBy Maureen Ryan dateCreated 2023-03-16 modifiedBy COLBERTM dateModified 2023-03-16 languageName ENGLISH name Not Reported type VM Alt Name context COG id F7E64D3D-671D-5F5B-E053-731AD00A7EA8 createdBy Angela Kummerow dateCreated 2023-03-27 modifiedBy KUMMEROA dateModified 2023-03-27 languageName ENGLISH name Not reported type Manually-curated context NCIP id 01E36070-B407-2894-E063-731AD00A26B9 createdBy Gwen Deen dateCreated 2023-08-01 modifiedBy GDEEN dateModified 2023-08-01 languageName ENGLISH name Not Stated type VM Alt Name context NCIP id 075F5912-5BB3-3B40-E063-731AD00A37FA createdBy Lamia Sokker dateCreated 2023-10-10 modifiedBy SOKKERL dateModified 2023-10-10 languageName ENGLISH name Not stated in Report type VM Alt Name context CCTG id 097FC64F-5B06-6592-E063-731AD00AC610 createdBy Cassandra Lohnes dateCreated 2023-11-06 modifiedBy CLOHNES dateModified 2023-11-06 languageName ENGLISH name Not Stated in Report type OID, CCTG context CCTG id 09A6371C-80E0-502C-E063-731AD00A26F5 createdBy Cassandra Lohnes dateCreated 2023-11-08 modifiedBy CLOHNES dateModified 2023-11-08 languageName ENGLISH name Not Reported type CRDC Alt Name context CRDC id 0F53F53A-F7B0-4F25-E063-731AD00A3B14 createdBy Bobbie Fincham dateCreated 2024-01-19 modifiedBy FINCHAMB dateModified 2024-01-19 languageName ENGLISH name -1 type TCIA Alt Name context CIP id 1F44C19A-94C2-5731-E063-731AD00AF175 createdBy Bobbie Fincham dateCreated 2024-08-09 modifiedBy FINCHAMB dateModified 2024-08-09 languageName ENGLISH name Not Reported type CDA Alt Name context CRDC id 2F8F12E0-3D58-33DC-E063-731AD00A3A1C createdBy Sarah Lauer dateCreated 2025-03-04 modifiedBy SLAUER dateModified 2025-03-04 languageName ENGLISH name not reported type CDA Alt Name context CRDC id 2F8F12E0-3D59-33DC-E063-731AD00A3A1C createdBy Sarah Lauer dateCreated 2025-03-04 modifiedBy SLAUER dateModified 2025-03-04 languageName ENGLISH name Not Reported type GC Alt Name context CRDC id 2F8F12E0-3D5A-33DC-E063-731AD00A3A1C createdBy Sarah Lauer dateCreated 2025-03-04 modifiedBy SLAUER dateModified 2025-03-04 languageName ENGLISH name Not Reported type GDC Alt Name context CRDC id 2F8F12E0-3D5B-33DC-E063-731AD00A3A1C createdBy Sarah Lauer dateCreated 2025-03-04 modifiedBy SLAUER dateModified 2025-03-04 languageName ENGLISH name Not Reported type PDC Alt Name context CRDC id 2F8F12E0-3D5C-33DC-E063-731AD00A3A1C createdBy Sarah Lauer dateCreated 2025-03-04 modifiedBy SLAUER dateModified 2025-03-04 languageName ENGLISH name Not Reported type HTAN Alt Name context HTAN id 2F8F12E0-3D5D-33DC-E063-731AD00A3A1C createdBy Sarah Lauer dateCreated 2025-03-04 modifiedBy SLAUER dateModified 2025-03-04 ConceptualDomain publicId 2435018 version 1 longName Clinical or Research Activity shortName C16203 definition Any specific activity undertaken during the course of a clinical study or research protocol. context NCIP origin NCI Thesaurus workflowStatus RELEASED registrationStatus Application latestVersionIndicator Yes beginDate 2005-12-06 endDate changeDescription administrativeNotes unresolvedIssues deletedIndicator No createdBy CURTIST dateCreated 2005-12-06 modifiedBy SBR dateModified 2006-12-20 RepresentationTerm publicId 7062947 version 1 longName Residual Disease Status shortName C4809:C25688 definition Cancer cells that remain after attempts to remove the cancer have been made.:A condition or state at a particular time. context NCIP origin workflowStatus RELEASED registrationStatus Application latestVersionIndicator Yes beginDate 2019-11-20 endDate changeDescription administrativeNotes unresolvedIssues deletedIndicator No createdBy KNABLEJ dateCreated 2019-11-20 modifiedBy ONEDATA dateModified 2019-11-20 Concepts longName Residual Disease conceptCode C4809 definition The persistence of tumor cells in the body following cancer treatment. evsSource NCI_CONCEPT_CODE primaryIndicator No displayOrder 1 longName Status conceptCode C25688 definition A condition or state at a particular time. evsSource NCI_CONCEPT_CODE primaryIndicator Yes displayOrder 0 ClassificationSchemes publicId 10466051 version 1 longName All CRDC Standard CDEs context CRDC workflowStatus RELEASED registrationStatus Application ClassificationSchemeItems publicId 14193212 version 1 longName Clinical Observation context CRDC workflowStatus RELEASED registrationStatus Application AlternateNames name Residual Disease Status type CRDC Alt Name context CRDC ReferenceDocuments documentName PQT documentText Residual Disease documentType Preferred Question Text url context CRDC

apiResponse

type S